SCHEMBL3609308

SCHEMBL3609308

CCOC(=O)CON1CCCCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.50
TSHR P16473 2/20 0.46
GAA P10253 2/20 0.41
MGAM O43451 1/20 0.41
SI P14410 1/20 0.41
MGAM2 Q2M2H8 1/20 0.41
ALDH1A1 P00352 6/20 0.39
TRPA1 O75762 1/20 0.39
GLA P06280 1/20 0.39
NPSR1 Q6W5P4 2/20 0.38
HSD17B10 Q99714 1/20 0.38
PRKCA P17252 1/20 0.38
GSK3B P49841 1/20 0.38
LMNA P02545 1/20 0.38
POLB P06746 1/20 0.38
MAPK1 P28482 1/20 0.37
THRB P10828 1/20 0.37
ATM Q13315 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
ELANE P08246 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18130832 0.76 ALDH1A1 (0.51) TSHRGAAALDH1A1PRKCAGSK3B
SCHEMBL28930531 0.76 LMNA (0.47) TSHRGAAMGAMSIMGAM2
SCHEMBL20382048 0.74 KMT2A (0.41) KMT2ATSHRGAAMGAMSI
SCHEMBL15414910 0.73 CYP1A2 (0.39) TSHRGAAALDH1A1POLBMAPK1
SCHEMBL865518 0.72 GAA (0.47) KMT2AGAAMGAMSIMGAM2
SCHEMBL8681288 0.72 ALDH1A1 (0.48) KMT2ATSHRALDH1A1NPSR1HSD17B10
SCHEMBL4080149 0.72 GAA (0.47) KMT2AGAAMGAMSIMGAM2
Methyl Alcohol SCHEMBL72604 0.72 CTSK (0.37) KMT2ATSHRALDH1A1HSD17B10POLB
SCHEMBL740948 0.71
Hydrochloric Acid SCHEMBL27504935 0.71 LMNA (0.47) KMT2AGAAMGAMSIMGAM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7759387-B2 Fibrinogen receptor antagonists and their use PIRAMAL LIFE SCIENCES LIMITED (IN) 2010-07-20 US disclosed
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
EP-1939205-A1 TRICYCLIC COMPOUND Daiichi Sankyo Company, Limited (JP) 2008-07-02 EP disclosed
US-20070021489-A1 Fibrinogen receptor antagonists and their use NICHOLAS PIRAMAL INDIA LIMITED (IN) 2007-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070021489-A1 Fibrinogen receptor antagonists and their use FGB, F13B, F2 KMT2A 4561/4885TSHR 163/4885GAA 3340/4885
US-20090181942-A1 TRICYCLIC COMPOUNDS FDFT1, COASY, HMGCR KMT2A 1467/4885TSHR 1672/4885GAA 922/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.